Neuronetics, Inc. (STIM) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Earnings Reports
-
Neuronetics (STIM) Q1 2026: Clinic Revenue Jumps 15% as Buy-and-Bill Drives Growth
May 05, 2026
-
Neuronetics (STIM) Q4 2025: Greenbrook Clinics Drive 28% Pro Forma Revenue Growth, Setting Stage for New Therapies
March 17, 2026
-
Neuronetics (STIM) Q3 2025: Greenbrook Clinics Surge 25%, Offsetting Neurostar Revenue Drag
November 04, 2025
-
Neuronetics (STIM) Q2 2025: Greenbrook Drives 23% Sequential Clinic Revenue Jump, Margin Mix in Focus
August 05, 2025
-
Neuronetics (STIM) Q2 2025: Greenbrook Drives 132% Revenue Surge, Margin Mix Shifts Shape Profit Path
August 05, 2025